Chronic Treatment with α-Lipoic Acid Improves Endothelium-Dependent Vasorelaxation of Aortas in High-Fat Diet-Fed Mice

• Published in: Biological & pharmaceutical bulletin 2019/09/01, Vol.42(9), pp.1456-1463
• Main Authors: Takenouchi, Yasuhiro, Tsuboi, Kazuhito, Ohsuka, Kenji, Nobe, Koji, Ohtake, Kazuo, Okamoto, Yasuo, Kasono, Keizo
• Format: Article
• Language: English
• Subjects: Animals; Antioxidants - administration & dosage; Antioxidants - pharmacology; Aorta - drug effects; Aorta - physiopathology; Blood Glucose - analysis; Body Weight - drug effects; Diet, High-Fat; Dietary Supplements; Dose-Response Relationship, Drug; endothelial dysfunction; Endothelium, Vascular - drug effects; Endothelium, Vascular - physiopathology; Lipids - blood; Male; Mice, Inbred ICR; obesity; Obesity - blood; Obesity - drug therapy; Obesity - physiopathology; oxidative stress; Oxidative Stress - drug effects; Thioctic Acid - administration & dosage; Thioctic Acid - pharmacology; thoracic aorta; Vasodilation - drug effects; vasorelaxation; α-lipoic acid
• ISSN: 0918-6158; 1347-5215
• DOI: 10.1248/bpb.b18-00800

α-Lipoic acid (ALA) is used as a dietary supplement and known as an anti-oxidant. The present study aimed to examine whether ALA improves endothelial dysfunction in high-fat diet-fed obese mice. After feeding a high-fat diet to Institute of Cancer Research (ICR) mice for 4 weeks, the mice were maintained with a high-fat diet (group HF) or a high-fat diet containing ALA (25 mg/d, group HF + ALA) for an additional 20 weeks. Age-matched normal diet-fed mice were also used (group Normal). Chronic oral treatment with ALA did not affect various plasma parameters or body weights. As compared with the aortas of Normal mice, those from HF mice showed impaired endothelium-dependent relaxation in response to clonidine. However, such an impairment was not observed in the aortas from HF + ALA mice. The plasma levels of thiobarbituric acid reactive substances, an indicator of oxidative stress, were significantly decreased in HF + ALA mice compared with HF mice, confirming the anti-oxidative effects of ALA. In addition, when the impaired clonidine-induced vasorelaxation of aortas from normal mice under high glucose conditions was used as a model of acute oxidative stress, the vasorelaxation responses were improved in the presence of ALA at 100 µM. Our results suggested that the chronic oral administration of ALA improves endothelial dysfunction in high-fat diet-fed obese mice possibly through the reduction in oxidative stress in vivo.